CRISPR Technology Market Size 2023: Technological Advancement, Application, Revenue, Types, Trends in Future, Scope to 2028 | Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (China)

CRISPR market in terms of revenue was estimated to be worth $3.4 Billion in 2023 and is poised to reach $7.1 Billion by 2028, growing at a CAGR of 15.6% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The major factors driving the growth of the CRISPR market are the advancements and increasing demand gene editing technology, and rising funding and investment of government and private organizations is expected to propel the growth of the market. However, ethical and regulatory considerations are expected to restrain market growth to a certain extent.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

CRISPR market major players covered in the report, such as:

Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Agilent Technologies Inc. (US)
Genscript Biotech Corporation (China)
CRISPR Therapeutics AG (Switzerland)
Editas Medicine (US)
Intellia Therapeutics Inc. (US)
Beam Therapeutics Inc. (US)
Caribou Biosciences Inc. (US)
Lonza Group Ltd. (Switzerland)
Danaher Corporation (US)
PerkinElmer Inc. (US)
Hera Biolabs (US)
OriGene Technologies Inc. (US)
Cellecta Inc. (US)
Mammoth Biosciences Inc. (US)
Applied StemCell (US)
New England Biolabs Inc. (US)
ToolGen Inc. (South Korea)
GeneCopoeia Inc. (US)
Twist Bioscience Corporation (US)
Synthego Corporation (US)
eGenesis (US)
Inscripta Inc. (US)
Precision BioSciences Inc. (US)
and Among Others

Buy CRISPR Industry Report (207 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=134401204&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

This report categorizes the CRISPR market into the following segments:

CRISPR Market, by product & services

Products

CRISPR kits & Enzymes
CRISPR Libraries
Other Products (design tools, antibodies, other reagents)
Services
gRNA Design & Vector Construction
Cell Line Engineering
Screening Services
Other Services (Epigenome Editing and Transcriptional Activation)

CRISPR Market, by Application

Drug discovery & development
Agriculture
Other applications (biofuels, veterinary)
CRISPR Market, by End User

Pharmaceutical & biotechnology companies
Academic & research institutes
Others (CROs & CDMOs)

CRISPR Market, by region

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe (RoE)
Asia Pacific (APAC)
Japan
India
China
Rest of Asia Pacific (RoAPAC)
Latin America
Brazil
RoLATAM
Middle East Africa

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=134401204&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

The key stakeholders in the CRISPR market include:

Manufacturers and distributors of CRISPR products
Pharmaceutical and biotechnology companies
Market research and consulting firms
R&D centers
Researchers and scientists
Academic & research institutes

Recent Developments:

In May 2023, Thermo Fisher Scientific opens cell therapy facility at UCSF to accelerate development of breakthrough therapies. Thermo Fisher Scientific Inc. and the University of California, San Francisco accelerated advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center's Mission Bay campus.

In April 2022, Thermo Fisher Scientific Inc. launched the new GMP-manufactured Gibco CTS TrueCut Cas9 Protein to support genome editing for research and manufacturing applications, including CAR T-cell therapy research.

In November 2021, GenScript announced today that it has launched the GenWand Double-Stranded DNA (dsDNA) Service for the manufacture of CRISPR knock-in homology- directed repair (HDR) templates in T cell engineering.

In October 2020, Merck announced that it signed agreements licensing its CRISPR technology to two companies PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.